Biologics Market – Scenario
The global biologics market is expected to gain prominence over the forecast period. It is estimated that the global biologics market is expected to grow at a CAGR of ~ 8.6% during the forecast period, 2017 to 2023. Biologics is a product that is produced from living organisms or certain components of living organisms. This includes a wide variety of products derived from animal, human, or microorganisms by using biotechnology. The increasing prevalence of chronic and acute diseases, growing demand for biologics, and increasing investments in research are driving the growth of the market. Moreover, continuous development in the healthcare sector and technological advancements in biologics are expected to contribute to the growth of the market during the forecast period.
Growing approval of medicines that are patient centric and personalized have added further impetus to the growth of the industry in the forecast period. The state of the medicine sector recently has created ample opportunities for the development of the market. High rates of approval for biologics have been the motivating factors behind the expansion of the market. Increased resistance to conventional drugs has prompted manufacturers to explore and invest in other opportunities. Rising number of market players will prompt improved growth of the market, especially through the forecast period.
Global Biologic Market is Expected to Grow at a CAGR of 8.6% during Forecasted Period 2017-2023.
Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/1339
Key Players for Global Biologics Market
Some of the key players in the global biologics market are Lundbeck (Denmark), Unilife Corporation (US), Sanofi (France), AstraZeneca (UK), Terumo Corporation (Japan), Pfizer Inc. (US), Roche Diagnostics (Switzerland), Amgen (US), GSK Biologicals (UK), Samsung Biologics (South Korea), Celltrion (South Korea), Addgene (US), Bayer AG (Germany), Genzyme (US) and Merck KGaA (Germany) are a few of the firms establishing their presence in the biologics market.
Biologics Industry Updates:
May 2018 Catalent had recently invested into a major move into contract biologics manufacturing last year when it spent $950m in the acquisition of Cook Pharmica. The transaction has given Catalent ownership of an 875,000-square-foot biologics facility in Indiana, US to supplement its current plant in Wisconsin, US. Catalent is now looking to expand both these facilities. Catalent’s aim in growing both sites echoes a belief that the contract biologics manufacturing industry is set for a period of continued growth.
Global Biologics Industry Competitive Analysis
The market trends have also necessitated the need to ensure financial sustainability to invest in growth opportunities as and when they arise. The objective of the firms in the market to grow their shareholder’s value, while enhancing the capability to power their competitive edge has enabled the company’s growth to a great extent. Challengers are also investing a certain amount in innovation so as to provide a certain degree of innovation in the market and expand the avenues for growth especially in the duration of the forecast period. The escalating interest in diversification within the business has indirectly allowed the businesses to utilize several situations obtainable in the market. The chances for increasing revenue inflow in the business are expected to multiply through the forecast period. Companies are also continually attempting to create financial leverage, so as to be better positioned to capitalize on market gains.
Segments for Global Biologics Market
The global biologics market is segmented on the basis of type, application, and source.
On the basis of type, the market is classified into vaccines, blood products, proteins, gene therapy, monoclonal antibodies, and others. The global biologics market on the basis of application is segmented into anemia, cancer, diabetes, and others. On the basis of source, the market is segmented as human, animal, and microorganism. Geographically, the market has been segmented into America, Europe, Asia-Pacific, and the Middle East and Africa. The American biologics market is further segmented into North America and South America. North America is further classified as the US and Canada. The European biologics market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The Asia-Pacific biologics market is segmented into Japan, China, India, the Republic of Korea, Australia, and the Rest of Asia-Pacific. The Middle Eastern and African biologics market is segmented into the Middle East and Africa.
Get Prime Discount on Report @ https://www.marketresearchfuture.com/check-discount/1339
Regional Analysis for Global Biologics Market
Europe, Asia Pacific, North America and rest of the world are the regions that are a part of the market. As per the regional analysis of the market, the North American region has the largest biologic drug market. Owing to growing incidence of diseases like cancer and diabetes in the North American region is the main factor for the development of the market. The European region shadows the North American region in the biologic market. The Asia Pacific region is the one of the swiftly growing regions for the market. Japan, China, and India majorly drive the progress of the biologic market in the Asia Pacific region. Furthermore, the huge population base in this region will fuel the growth of the market over the forecast period. The Middle East and Africa region have the least share in the biologic market region among the regions
Some Major Chapters From Table of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Biologics Market, By Type
Chapter 7. Global Biologics Market, By Application
Chapter 9. Global Biologics Market, By Region
Chapter 10. Company Landscape
Chapter 11. Company Profiles
Chapter 13 Appendix
TOC Continued…
Do You Have Specific Requirement? Ask To Our Experts@ https://www.marketresearchfuture.com/enquiry/1339
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/biologics-market-1339